SAN FRANCISCO--(BUSINESS WIRE)--ClinStar, LLC, an established clinical research organization providing clinical development services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that they will host a live webinar entitled “5 Keys to Successful Clinical Trial Logistics in Russia and Eastern Europe.”
With patient enrollment rates up to twenty times faster than the West, the pharmaceutical and biotechnology industry is embracing the undeniable benefits of conducting clinical trials in emerging markets such as Russia. In fact, 33% of all drugs approved by the FDA and 48% of all drugs approved by the EMEA in 2011 included data from clinical development conducted in this region.
Yet with benefits like this, many organizations still have negative perceptions of working in this region due to fear of prolonged study start-up times and unknown regulatory and logistics requirements. For clinical trial logistics alone, Sponsors may have a number of questions or uncertainties, including:
- How will the study drug be imported into the country?
- Where will it be stored?
- How will it get to the remote locations of trial sites?
- How can I ensure there will be no temperature deviations along the way?
- What happens to the unused drug supply?
During the webinar, ClinStar CEO David Passov will begin the presentation with a discussion about the benefits of conducting clinical trials in Russia and parts of Eastern Europe compared to other emerging markets. ClinStar/IMP Logistics VP & General Counsel Leon Dzivinsky will follow and address many of the questions and concerns Sponsors have about logistics and introduce five keys to successfully managing clinical trial logistics in this region.
ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical development in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages clinical trials from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.